Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 301–325 of 27,380 studies, newest first · page 13 of 1096.

October 2026 7

  1. 2026-10-01

    Shared and Divergent Multisensory Emotion Perception Deficits across Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia: A Systematic Review and Hierarchical Bayesian Meta-Analysis

    ⚠ Preprint — not yet peer-reviewed Risk factors PsyArXiv

    Key finding: Meta-analytic results demonstrated a differential magnitude of MEP impairment across groups (FTD > AD > MCI), reflecting distinct socio-emotional vulnerabilities rather than a single disease continuum. +2 more findings

    Scored 56 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-10-01

    Docking-Guided Design and Biological Evaluation of a Lead Convolvine-Based Acetylcholinesterase Inhibitor for Alzheimer's Disease

    ⚠ Preprint — not yet peer-reviewed Treatments Research Square

    Key finding: Significant AChE inhibitory action with potency comparable to the standard was confirmed by in vitro assessment. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-10-01

    T1R2/T1R3 Identified as the Aβ Receptor: A New Mechanism Linking Aβ42/40 Ratio to Neuronal Hyperexcitability in Alzheimer’s Disease

    ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv

    Key finding: These findings identify T1R2/T1R3 as the receptor that detects the Aβ42/40 ratio, link early Aβ changes to hyperexcitability, and point to a therapeutic target for restoring early neuronal function. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2026-10 month only

    Sex-specific brain reserve and progression from mild cognitive impairment to Alzheimer's disease dementia

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Females with MCI exhibited greater baseline GMV than males primarily in the thalamus, caudate, cerebellum, postcentral gyrus, and middle cingulate gyrus, with no differences at the AD stage. +2 more findings

  5. 2026-10 month only

    Context-dependent TREM2 signalling in myeloid cells: Molecular mechanisms and immunotherapeutic divergence in neurodegeneration and cancer

    ✓ Peer-reviewed TREM2 and immune genetics Clinical and translational medicine

    Key finding: We address translation bottlenecks-including blood-brain barrier (BBB) shuttles, human trial scarcity and soluble TREM2 (sTREM2) biomarker harmonisation-outlining a biomarker-guided, context-tailored precision therapeutic framework for targeting the TREM2 axis.

  6. 2026-10-01

    Tau extent is associated with lower cognition in Down syndrome-related Alzheimer's disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: This first evaluation of 18 F-MK6240 in DS demonstrates its suitability as a sensitive biomarker for Alzheimer's disease tau pathology. +1 more finding

  7. 2026-10-01

    Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: False-positive (FP) plasma results may lead to overtreatment and false-negative (FN) results to missed or delayed disease-modifying therapies. +4 more findings

September 2026 18

  1. 2026-09-30

    Mapping Gut Dysbiosis in Alzheimer’s using ML

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Research Square

    Key finding: Alzheimer’s disease is a progressive, currently irreversible, neurodegenerative disorder associated with the accumulation of β-Amyloid (Aβ) plaques between cells and tau (τ) tangles within cells. +4 more findings

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-09-30

    Newly diagnosed postoperative depression and incident dementia after major surgery: a Korean nationwide retrospective cohort study

    ⚠ Preprint — not yet peer-reviewed Risk factors Research Square

    Key finding: Newly diagnosed postoperative depression was associated with increased dementia risk, particularly in patients aged < 65 years, supporting prospective evaluation as a potential marker of long-term cognitive risk. +3 more findings

    Scored 52 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-09-30

    Mobile Clinics for Brain Health Equity: A Feasibility Study of Dementia Risk Reduction in Underserved Communities

    ⚠ Preprint — not yet peer-reviewed Prevention trials Research Square

    Key finding: Recruitment (88.0%) and protocol fidelity (100%) met or exceeded prespecified progression criteria, whereas retention and follow-up data availability were 59.1% (13/22), slightly below the predefined 60% criterion. +4 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2026-09-30

    Predicting Rates of Cognitive Decline in Older Adults with Brain- and Cardiac-Imputed Transcripts

    ⚠ Preprint — not yet peer-reviewed Drug development medRxiv

    Key finding: Changes in heart and brain tissue have been associated with cognitive decline, yet tissue-specific molecular data are difficult to obtain. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  5. 2026-09-30

    Glial Transcriptomic Convergence in Alzheimer’s and Parkinson’s Disease with Independent Retinal and Aqueous-Humor Evidence

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Preprints.org

    Key finding: We then integrated healthy retinal expression, AD retinal proteomics, and PD aqueous-humor proteomics with the brain-concordance results. +2 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2026-09-30

    Evaluation of plasma neurofilament and glial fibrillary acidic protein to predict or detect amyloid related imaging abnormalities

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Baseline NfL and GFAP did not differ between patients with or without ARIA (ln[NfL] ECLIA 1.24 ± 0.38 pg/mL vs 1.25 ± 0.40 pg/mL, p = 0.77; ln[NfL] Simoa 2.87 ± 0.47 pg/mL vs 2.98 ± 0.40 pg/mL, p = 0.30, ln[GFAP] ECLIA 4.95 ± 0.36 pg/mL vs 4.88 ± 0.47 pg/mL, p = 0.69). +3 more findings

  7. 2026-09-29

    Expert-Derived Components of Person-Centred Nursing Intervention for People with Dementia and/or Cognitive Impairment in a Hospital Experiencing Distress

    ⚠ Preprint — not yet peer-reviewed Clinical safety Research Square

    Key finding: Thorough and structured assessment is essential for identifying unmet needs and managing distress in people with dementia in acute hospitals.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2026-09-29

    Person-Centred Care: Impact on the Effectiveness of Palliative Care in Patients with Alzheimer’s Disease

    ⚠ Preprint — not yet peer-reviewed End-of-life care Research Square

    Key finding: Sixteen eligible studies with heterogeneous designs were included, and owing to methodological and outcome variability, the results were synthesized narratively. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-09-29

    Co-adapting the GRACE (Goal-diRected ACcessible, Equitable, Evidence-based Care) Dementia Post-diagnostic Support Intervention to Improve Inclusivity

    ⚠ Preprint — not yet peer-reviewed Caregiving Research Square

    Key finding: GRACE has demonstrated clinical and cost-effectiveness in trial settings, providing a strong foundation for wider implementation. +1 more finding

    Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2026-09-29

    Apigenin Improves Healthspan and Protects Against Alzheimer’s Disease-Associated Proteotoxicity in C. elegans

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms bioRxiv

    Key finding: We found that chronic exposure to apigenin extended median lifespan and improved multiple readouts of healthspan, including pharyngeal pumping, locomotor activity, and age-related macromolecular damage accumulation. +3 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  11. 2026-09-29

    Gut Microbiota–Host Metabolic Networks in Alzheimer’s Disease: From Pathological Mechanisms to Modulation by Traditional Chinese Medicine

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Authorea Preprints

    Key finding: Growing evidence suggests that gut–brain communication mediated by the gut microbiota and microbiota-related metabolic signals is closely associated with AD pathology.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  12. 2026-09-29

    Clinically Recognised Alcohol Use Disorder and Risk of Dementia Subtypes in 1.3 Million Women: A Prospective Cohort Study

    ⚠ Preprint — not yet peer-reviewed Prevention and risk medRxiv

    Key finding: Among 1,288,359 women, 20,070 with AUD were matched to 100,339 controls. +2 more findings

    Scored 39 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-09-29

    Evaluating Diabetes Drug Targets for Vascular Dementia Prevention Using Drug Target Mendelian Randomisation

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv

    Key finding: In primary HbA1c-scaled analyses, no antidiabetic drug target showed evidence of association with VaD risk or cerebrovascular neuroimaging markers, although DPP4 inhibition demonstrated a suggestive protective association for VaD (OR = 0.68, 95% CI = 0.46 - 1.02, p = 0.063), though the confidence interval (CI) included the null. +1 more finding

    Scored 37 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  14. 2026-09-29

    Diagnostic Utility of Multi-Domain Language Measures Across the Alzheimer Disease Continuum

    ⚠ Preprint — not yet peer-reviewed Prevention trials medRxiv

    Key finding: Eight of 12 measures reached acceptable discrimination (AUC ≥ .700) for DAT vs. Semantic fluency showed the highest discrimination in each contrast, though it did not significantly outperform the NAT-S for MCI vs. In a post hoc regression, adjusting for cognitive flexibility and working memory attenuated group differences; the DAT difference was no longer significant, whereas the MCI difference remained significant. +2 more findings

    Scored 29 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  15. 2026-09-29

    APOE ε4 Carrier Status and Cognitive Decline in Mild-to-Moderate Alzheimer’s Disease: A Linear Mixed-Effects Analysis of the Placebo Arm of EXPEDITION 1

    ⚠ Preprint — not yet peer-reviewed Treatments medRxiv

    Key finding: In this cohort, APOE ε4 carrier status was related to disease severity at baseline rather than to the rate of cognitive decline over 80 weeks. +2 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  16. 2026-09-29

    A systems-level model of sleep-dependent memory-consolidation failure in neurodegeneration: the spindle–slow-oscillation decoupling cascade dissociates amyloid and tau

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging bioRxiv

    Key finding: We built a computer model that reproduces the rhythms and, crucially, lets the measured timing between slow waves and spindles control how strongly memories are written into cortex. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  17. 2026-09-29

    Normative Modeling of Molecular-Enriched Functional Connectivity for Detecting Deviations from Healthy Brain Aging

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging bioRxiv

    Key finding: Of 204 normative reference models, 199 (97.5%) met the predefined diagnostic criteria; median held-out explained variance (EXPV) was 0.174. +1 more finding

    Scored 47 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-09-29

    Regional similarity to male-typical brain architecture links childhood ADHD to neurophysiological aging in later adulthood

    ⚠ Preprint — not yet peer-reviewed Genetics bioRxiv

    Key finding: Our results imply that neurodevelopmental conditions could provide insights into vulnerability to suboptimal aging trajectories and could help guide early interventions targeting at-risk individuals.

    Scored 29 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →